Antifungal Drugs research

Antifungal Drugs Comprehensive Study by Type (Gels, Cream, Shampoo, Injections, Liquids or Spray, Tablets (Pill)), Drugs (Azoles, Echinocandins, Polyenes, Others), Distribution Channel (Speciality clinics, Hospital pharmacies, Retail pharmacies, E-commerce), Dosage form (Oral, Topical, Intravenous, Intravaginal), Diseases (Candidiasis, Aspergillosis, Cryptococcosis, Dermatophytosis) Players and Region - Global Market Outlook to 2027

Antifungal Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Antifungal Drugs are used for treatment of fungal infections with minimal side effects on the body. There are some common fungal infections such as ringworm, athlete’s foot and vaginal thrush which are get cure by antifungal drugs. The antifungal drugs market is mainly driven by the incidence and prevalence rate of the antifungal infections. Moreover due to benefits such as cost effective products, rising population of immune compromised individuals and minimal side-effects physician are prescribing these products. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the Healthcare sector.This growth is primarily driven by Rising Incidence of Fungal Infections. .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Bayer AG (Germany), Astellas (Japan), Merck & Co., Inc. (United States), Sanofi (France), Pfizer Inc. (United States) and Novartis AG (Switzerland), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.



Influencing Trend:
Increasing Awareness towards Personal Safety and Health Care and Demand of Anti Fungal Drugs due to High prevalence of Mycological Infections

Market Growth Drivers:
Rising Incidence of Fungal Infections. and Increasing R & D Pertaining to the Development of Novel Drugs.

Restraints:
Presence of Generic Competition Hampers the Anti-Fungal Drugs Market. and Rising Resistance to Antifungal Drugs.

Opportunities:
Numerous Ongoing Public Private Partnership Agreements in the Pharmaceutical Industry. and Rising Government Initiatives to Create Awareness of Infectious Diseases Among the Population.

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Antifungal Drugs Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Antifungal Drugs Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Antifungal Drugs players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Antifungal Drugs Study Sheds Light on
— The Antifungal Drugs Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Antifungal Drugs industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Antifungal Drugs industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Gels
  • Cream
  • Shampoo
  • Injections
  • Liquids or Spray
  • Tablets (Pill)
By Drugs
  • Azoles
  • Echinocandins
  • Polyenes
  • Others

By Distribution Channel
  • Speciality clinics
  • Hospital pharmacies
  • Retail pharmacies
  • E-commerce

By Dosage form
  • Oral
  • Topical
  • Intravenous
  • Intravaginal

By Diseases
  • Candidiasis
  • Aspergillosis
  • Cryptococcosis
  • Dermatophytosis

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence of Fungal Infections.
      • 3.2.2. Increasing R & D Pertaining to the Development of Novel Drugs.
    • 3.3. Market Trends
      • 3.3.1. Increasing Awareness towards Personal Safety and Health Care
      • 3.3.2. Demand of Anti Fungal Drugs due to High prevalence of Mycological Infections
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antifungal Drugs, by Type, Drugs, Distribution Channel, Dosage form, Diseases and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Antifungal Drugs (Value)
      • 5.2.1. Global Antifungal Drugs by: Type (Value)
        • 5.2.1.1. Gels
        • 5.2.1.2. Cream
        • 5.2.1.3. Shampoo
        • 5.2.1.4. Injections
        • 5.2.1.5. Liquids or Spray
        • 5.2.1.6. Tablets (Pill)
      • 5.2.2. Global Antifungal Drugs by: Drugs (Value)
        • 5.2.2.1. Azoles
        • 5.2.2.2. Echinocandins
        • 5.2.2.3. Polyenes
        • 5.2.2.4. Others
      • 5.2.3. Global Antifungal Drugs by: Distribution Channel (Value)
        • 5.2.3.1. Speciality clinics
        • 5.2.3.2. Hospital pharmacies
        • 5.2.3.3. Retail pharmacies
        • 5.2.3.4. E-commerce
      • 5.2.4. Global Antifungal Drugs by: Dosage form (Value)
        • 5.2.4.1. Oral
        • 5.2.4.2. Topical
        • 5.2.4.3. Intravenous
        • 5.2.4.4. Intravaginal
      • 5.2.5. Global Antifungal Drugs by: Diseases (Value)
        • 5.2.5.1. Candidiasis
        • 5.2.5.2. Aspergillosis
        • 5.2.5.3. Cryptococcosis
        • 5.2.5.4. Dermatophytosis
      • 5.2.6. Global Antifungal Drugs Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Antifungal Drugs (Price)
      • 5.3.1. Global Antifungal Drugs by: Type (Price)
  • 6. Antifungal Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bayer AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Astellas (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck & Co., Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sanofi (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novartis AG (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Antifungal Drugs Sale, by Type, Drugs, Distribution Channel, Dosage form, Diseases and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Antifungal Drugs (Value)
      • 7.2.1. Global Antifungal Drugs by: Type (Value)
        • 7.2.1.1. Gels
        • 7.2.1.2. Cream
        • 7.2.1.3. Shampoo
        • 7.2.1.4. Injections
        • 7.2.1.5. Liquids or Spray
        • 7.2.1.6. Tablets (Pill)
      • 7.2.2. Global Antifungal Drugs by: Drugs (Value)
        • 7.2.2.1. Azoles
        • 7.2.2.2. Echinocandins
        • 7.2.2.3. Polyenes
        • 7.2.2.4. Others
      • 7.2.3. Global Antifungal Drugs by: Distribution Channel (Value)
        • 7.2.3.1. Speciality clinics
        • 7.2.3.2. Hospital pharmacies
        • 7.2.3.3. Retail pharmacies
        • 7.2.3.4. E-commerce
      • 7.2.4. Global Antifungal Drugs by: Dosage form (Value)
        • 7.2.4.1. Oral
        • 7.2.4.2. Topical
        • 7.2.4.3. Intravenous
        • 7.2.4.4. Intravaginal
      • 7.2.5. Global Antifungal Drugs by: Diseases (Value)
        • 7.2.5.1. Candidiasis
        • 7.2.5.2. Aspergillosis
        • 7.2.5.3. Cryptococcosis
        • 7.2.5.4. Dermatophytosis
      • 7.2.6. Global Antifungal Drugs Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Antifungal Drugs (Price)
      • 7.3.1. Global Antifungal Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antifungal Drugs: by Type(USD Million)
  • Table 2. Antifungal Drugs Gels , by Region USD Million (2016-2021)
  • Table 3. Antifungal Drugs Cream , by Region USD Million (2016-2021)
  • Table 4. Antifungal Drugs Shampoo , by Region USD Million (2016-2021)
  • Table 5. Antifungal Drugs Injections , by Region USD Million (2016-2021)
  • Table 6. Antifungal Drugs Liquids or Spray , by Region USD Million (2016-2021)
  • Table 7. Antifungal Drugs Tablets (Pill) , by Region USD Million (2016-2021)
  • Table 8. Antifungal Drugs: by Drugs(USD Million)
  • Table 9. Antifungal Drugs Azoles , by Region USD Million (2016-2021)
  • Table 10. Antifungal Drugs Echinocandins , by Region USD Million (2016-2021)
  • Table 11. Antifungal Drugs Polyenes , by Region USD Million (2016-2021)
  • Table 12. Antifungal Drugs Others , by Region USD Million (2016-2021)
  • Table 13. Antifungal Drugs: by Distribution Channel(USD Million)
  • Table 14. Antifungal Drugs Speciality clinics , by Region USD Million (2016-2021)
  • Table 15. Antifungal Drugs Hospital pharmacies , by Region USD Million (2016-2021)
  • Table 16. Antifungal Drugs Retail pharmacies , by Region USD Million (2016-2021)
  • Table 17. Antifungal Drugs E-commerce , by Region USD Million (2016-2021)
  • Table 18. Antifungal Drugs: by Dosage form(USD Million)
  • Table 19. Antifungal Drugs Oral , by Region USD Million (2016-2021)
  • Table 20. Antifungal Drugs Topical , by Region USD Million (2016-2021)
  • Table 21. Antifungal Drugs Intravenous , by Region USD Million (2016-2021)
  • Table 22. Antifungal Drugs Intravaginal , by Region USD Million (2016-2021)
  • Table 23. Antifungal Drugs: by Diseases(USD Million)
  • Table 24. Antifungal Drugs Candidiasis , by Region USD Million (2016-2021)
  • Table 25. Antifungal Drugs Aspergillosis , by Region USD Million (2016-2021)
  • Table 26. Antifungal Drugs Cryptococcosis , by Region USD Million (2016-2021)
  • Table 27. Antifungal Drugs Dermatophytosis , by Region USD Million (2016-2021)
  • Table 28. South America Antifungal Drugs, by Country USD Million (2016-2021)
  • Table 29. South America Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 30. South America Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 31. South America Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 32. South America Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 33. South America Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 34. Brazil Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 35. Brazil Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 36. Brazil Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 37. Brazil Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 38. Brazil Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 39. Argentina Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 40. Argentina Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 41. Argentina Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 42. Argentina Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 43. Argentina Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 44. Rest of South America Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 45. Rest of South America Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 46. Rest of South America Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 47. Rest of South America Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 48. Rest of South America Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 49. Asia Pacific Antifungal Drugs, by Country USD Million (2016-2021)
  • Table 50. Asia Pacific Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 51. Asia Pacific Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 52. Asia Pacific Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 53. Asia Pacific Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 54. Asia Pacific Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 55. China Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 56. China Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 57. China Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 58. China Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 59. China Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 60. Japan Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 61. Japan Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 62. Japan Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 63. Japan Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 64. Japan Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 65. India Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 66. India Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 67. India Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 68. India Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 69. India Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 70. South Korea Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 71. South Korea Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 72. South Korea Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 73. South Korea Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 74. South Korea Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 75. Taiwan Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 76. Taiwan Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 77. Taiwan Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 78. Taiwan Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 79. Taiwan Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 80. Australia Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 81. Australia Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 82. Australia Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 83. Australia Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 84. Australia Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 85. Rest of Asia-Pacific Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 86. Rest of Asia-Pacific Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 87. Rest of Asia-Pacific Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 88. Rest of Asia-Pacific Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 89. Rest of Asia-Pacific Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 90. Europe Antifungal Drugs, by Country USD Million (2016-2021)
  • Table 91. Europe Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 92. Europe Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 93. Europe Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 94. Europe Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 95. Europe Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 96. Germany Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 97. Germany Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 98. Germany Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 99. Germany Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 100. Germany Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 101. France Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 102. France Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 103. France Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 104. France Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 105. France Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 106. Italy Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 107. Italy Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 108. Italy Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 109. Italy Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 110. Italy Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 111. United Kingdom Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 112. United Kingdom Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 113. United Kingdom Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 114. United Kingdom Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 115. United Kingdom Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 116. Netherlands Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 117. Netherlands Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 118. Netherlands Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 119. Netherlands Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 120. Netherlands Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 121. Rest of Europe Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 122. Rest of Europe Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 123. Rest of Europe Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 124. Rest of Europe Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 125. Rest of Europe Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 126. MEA Antifungal Drugs, by Country USD Million (2016-2021)
  • Table 127. MEA Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 128. MEA Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 129. MEA Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 130. MEA Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 131. MEA Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 132. Middle East Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 133. Middle East Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 134. Middle East Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 135. Middle East Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 136. Middle East Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 137. Africa Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 138. Africa Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 139. Africa Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 140. Africa Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 141. Africa Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 142. North America Antifungal Drugs, by Country USD Million (2016-2021)
  • Table 143. North America Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 144. North America Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 145. North America Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 146. North America Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 147. North America Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 148. United States Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 149. United States Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 150. United States Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 151. United States Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 152. United States Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 153. Canada Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 154. Canada Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 155. Canada Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 156. Canada Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 157. Canada Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 158. Mexico Antifungal Drugs, by Type USD Million (2016-2021)
  • Table 159. Mexico Antifungal Drugs, by Drugs USD Million (2016-2021)
  • Table 160. Mexico Antifungal Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 161. Mexico Antifungal Drugs, by Dosage form USD Million (2016-2021)
  • Table 162. Mexico Antifungal Drugs, by Diseases USD Million (2016-2021)
  • Table 163. Antifungal Drugs: by Type(USD/Units)
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Antifungal Drugs: by Type(USD Million)
  • Table 171. Antifungal Drugs Gels , by Region USD Million (2022-2027)
  • Table 172. Antifungal Drugs Cream , by Region USD Million (2022-2027)
  • Table 173. Antifungal Drugs Shampoo , by Region USD Million (2022-2027)
  • Table 174. Antifungal Drugs Injections , by Region USD Million (2022-2027)
  • Table 175. Antifungal Drugs Liquids or Spray , by Region USD Million (2022-2027)
  • Table 176. Antifungal Drugs Tablets (Pill) , by Region USD Million (2022-2027)
  • Table 177. Antifungal Drugs: by Drugs(USD Million)
  • Table 178. Antifungal Drugs Azoles , by Region USD Million (2022-2027)
  • Table 179. Antifungal Drugs Echinocandins , by Region USD Million (2022-2027)
  • Table 180. Antifungal Drugs Polyenes , by Region USD Million (2022-2027)
  • Table 181. Antifungal Drugs Others , by Region USD Million (2022-2027)
  • Table 182. Antifungal Drugs: by Distribution Channel(USD Million)
  • Table 183. Antifungal Drugs Speciality clinics , by Region USD Million (2022-2027)
  • Table 184. Antifungal Drugs Hospital pharmacies , by Region USD Million (2022-2027)
  • Table 185. Antifungal Drugs Retail pharmacies , by Region USD Million (2022-2027)
  • Table 186. Antifungal Drugs E-commerce , by Region USD Million (2022-2027)
  • Table 187. Antifungal Drugs: by Dosage form(USD Million)
  • Table 188. Antifungal Drugs Oral , by Region USD Million (2022-2027)
  • Table 189. Antifungal Drugs Topical , by Region USD Million (2022-2027)
  • Table 190. Antifungal Drugs Intravenous , by Region USD Million (2022-2027)
  • Table 191. Antifungal Drugs Intravaginal , by Region USD Million (2022-2027)
  • Table 192. Antifungal Drugs: by Diseases(USD Million)
  • Table 193. Antifungal Drugs Candidiasis , by Region USD Million (2022-2027)
  • Table 194. Antifungal Drugs Aspergillosis , by Region USD Million (2022-2027)
  • Table 195. Antifungal Drugs Cryptococcosis , by Region USD Million (2022-2027)
  • Table 196. Antifungal Drugs Dermatophytosis , by Region USD Million (2022-2027)
  • Table 197. South America Antifungal Drugs, by Country USD Million (2022-2027)
  • Table 198. South America Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 199. South America Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 200. South America Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 201. South America Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 202. South America Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 203. Brazil Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 204. Brazil Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 205. Brazil Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 206. Brazil Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 207. Brazil Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 208. Argentina Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 209. Argentina Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 210. Argentina Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 211. Argentina Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 212. Argentina Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 213. Rest of South America Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 214. Rest of South America Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 215. Rest of South America Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 216. Rest of South America Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 217. Rest of South America Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 218. Asia Pacific Antifungal Drugs, by Country USD Million (2022-2027)
  • Table 219. Asia Pacific Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 220. Asia Pacific Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 221. Asia Pacific Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 222. Asia Pacific Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 223. Asia Pacific Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 224. China Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 225. China Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 226. China Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 227. China Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 228. China Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 229. Japan Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 230. Japan Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 231. Japan Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 232. Japan Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 233. Japan Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 234. India Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 235. India Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 236. India Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 237. India Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 238. India Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 239. South Korea Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 240. South Korea Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 241. South Korea Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 242. South Korea Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 243. South Korea Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 244. Taiwan Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 245. Taiwan Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 246. Taiwan Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 247. Taiwan Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 248. Taiwan Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 249. Australia Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 250. Australia Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 251. Australia Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 252. Australia Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 253. Australia Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 254. Rest of Asia-Pacific Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 255. Rest of Asia-Pacific Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 256. Rest of Asia-Pacific Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 257. Rest of Asia-Pacific Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 258. Rest of Asia-Pacific Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 259. Europe Antifungal Drugs, by Country USD Million (2022-2027)
  • Table 260. Europe Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 261. Europe Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 262. Europe Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 263. Europe Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 264. Europe Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 265. Germany Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 266. Germany Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 267. Germany Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 268. Germany Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 269. Germany Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 270. France Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 271. France Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 272. France Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 273. France Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 274. France Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 275. Italy Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 276. Italy Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 277. Italy Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 278. Italy Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 279. Italy Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 280. United Kingdom Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 281. United Kingdom Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 282. United Kingdom Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 283. United Kingdom Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 284. United Kingdom Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 285. Netherlands Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 286. Netherlands Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 287. Netherlands Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 288. Netherlands Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 289. Netherlands Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 290. Rest of Europe Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 291. Rest of Europe Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 292. Rest of Europe Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 293. Rest of Europe Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 294. Rest of Europe Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 295. MEA Antifungal Drugs, by Country USD Million (2022-2027)
  • Table 296. MEA Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 297. MEA Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 298. MEA Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 299. MEA Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 300. MEA Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 301. Middle East Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 302. Middle East Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 303. Middle East Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 304. Middle East Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 305. Middle East Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 306. Africa Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 307. Africa Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 308. Africa Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 309. Africa Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 310. Africa Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 311. North America Antifungal Drugs, by Country USD Million (2022-2027)
  • Table 312. North America Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 313. North America Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 314. North America Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 315. North America Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 316. North America Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 317. United States Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 318. United States Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 319. United States Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 320. United States Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 321. United States Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 322. Canada Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 323. Canada Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 324. Canada Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 325. Canada Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 326. Canada Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 327. Mexico Antifungal Drugs, by Type USD Million (2022-2027)
  • Table 328. Mexico Antifungal Drugs, by Drugs USD Million (2022-2027)
  • Table 329. Mexico Antifungal Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 330. Mexico Antifungal Drugs, by Dosage form USD Million (2022-2027)
  • Table 331. Mexico Antifungal Drugs, by Diseases USD Million (2022-2027)
  • Table 332. Antifungal Drugs: by Type(USD/Units)
  • Table 333. Research Programs/Design for This Report
  • Table 334. Key Data Information from Secondary Sources
  • Table 335. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antifungal Drugs: by Type USD Million (2016-2021)
  • Figure 5. Global Antifungal Drugs: by Drugs USD Million (2016-2021)
  • Figure 6. Global Antifungal Drugs: by Distribution Channel USD Million (2016-2021)
  • Figure 7. Global Antifungal Drugs: by Dosage form USD Million (2016-2021)
  • Figure 8. Global Antifungal Drugs: by Diseases USD Million (2016-2021)
  • Figure 9. South America Antifungal Drugs Share (%), by Country
  • Figure 10. Asia Pacific Antifungal Drugs Share (%), by Country
  • Figure 11. Europe Antifungal Drugs Share (%), by Country
  • Figure 12. MEA Antifungal Drugs Share (%), by Country
  • Figure 13. North America Antifungal Drugs Share (%), by Country
  • Figure 14. Global Antifungal Drugs: by Type USD/Units (2016-2021)
  • Figure 15. Global Antifungal Drugs share by Players 2021 (%)
  • Figure 16. Global Antifungal Drugs share by Players (Top 3) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Bayer AG (Germany) Revenue: by Geography 2021
  • Figure 20. Astellas (Japan) Revenue, Net Income and Gross profit
  • Figure 21. Astellas (Japan) Revenue: by Geography 2021
  • Figure 22. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Merck & Co., Inc. (United States) Revenue: by Geography 2021
  • Figure 24. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 25. Sanofi (France) Revenue: by Geography 2021
  • Figure 26. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Pfizer Inc. (United States) Revenue: by Geography 2021
  • Figure 28. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Novartis AG (Switzerland) Revenue: by Geography 2021
  • Figure 30. Global Antifungal Drugs: by Type USD Million (2022-2027)
  • Figure 31. Global Antifungal Drugs: by Drugs USD Million (2022-2027)
  • Figure 32. Global Antifungal Drugs: by Distribution Channel USD Million (2022-2027)
  • Figure 33. Global Antifungal Drugs: by Dosage form USD Million (2022-2027)
  • Figure 34. Global Antifungal Drugs: by Diseases USD Million (2022-2027)
  • Figure 35. South America Antifungal Drugs Share (%), by Country
  • Figure 36. Asia Pacific Antifungal Drugs Share (%), by Country
  • Figure 37. Europe Antifungal Drugs Share (%), by Country
  • Figure 38. MEA Antifungal Drugs Share (%), by Country
  • Figure 39. North America Antifungal Drugs Share (%), by Country
  • Figure 40. Global Antifungal Drugs: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Bayer AG (Germany)
  • Astellas (Japan)
  • Merck & Co., Inc. (United States)
  • Sanofi (France)
  • Pfizer Inc. (United States)
  • Novartis AG (Switzerland)
Select User Access Type

Key Highlights of Report


Mar 2024 223 Pages 88 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Antifungal Drugs research Quantitative research analysis
Antifungal Drugs research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Antifungal Drugs Market are Bayer AG (Germany), Astellas (Japan), Merck & Co., Inc. (United States), Sanofi (France), Pfizer Inc. (United States) and Novartis AG (Switzerland) etc.
AMA Research predicts that United States Players will contribute to the maximum growth of Global Antifungal Drugs market throughout the forecasted period.

Know More About Antifungal Drugs research Report?

Have a Query? Click Here

Other Related Reports

Resveratrol Comprehensive Study by Type (Natural, Artificial), Application (Dietary supplements, Pharmaceutical, Personal care products, Others), Form (Solid, Liquid) Players and Region - Global Mark...
$ 3500
Atopic Dermatitis Drugs Comprehensive Study by Type (Topical, Injectable, Oral), Application (Hospital, Clinic, Home care.), Distribution Channel (Hospital Pharmacies , Retail Pharmacies , Online Pha...
$ 3650
Health and Wellness Comprehensive Study by Type (Health and Wellness Food (Functional food, Naturally health food, Better-for-you (BFY) food, Food intolerance products, Organic food), Health and Well...
$ 3750
Antiepileptic Drugs Comprehensive Study by Drug (First Generation, Second Generation, Pipeline Drugs), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail P...
$ 3450
Prenatal Vitamin Supplements Comprehensive Study by Type (Folic Acid, Calcium, Iron, Vitamin D, Others), Distribution Channels (Retail Stores, Direct Selling, Online Stores), Dosage Forms (Capsule, P...
$ 3500
Ayurvedic Medicine Comprehensive Study by Type (Healthcare Products, Personal Care Products, Skin Care, Hair Care, Oral Care, Others), Application (Skin Diseases, Cardiovascular, Diabetes, Autoimmune...
$ 3750